APA (7th ed.) Citation

Everts-Graber, J., Bonel, H., Lehmann, D., Gahl, B., Häuselmann, H., Studer, U., . . . Lehmann, T. (2023). Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporosis International, 34(11), 1961. https://doi.org/10.1007/s00198-023-06863-y

Chicago Style (17th ed.) Citation

Everts-Graber, Judith, Harald Bonel, Daniel Lehmann, Brigitta Gahl, HansJörg Häuselmann, Ueli Studer, Hans-Rudolf Ziswiler, Stephan Reichenbach, and Thomas Lehmann. "Comparison of Anti-fracture Effectiveness of Zoledronate, Ibandronate and Alendronate Versus Denosumab in a Registry-based Cohort Study." Osteoporosis International 34, no. 11 (2023): 1961. https://doi.org/10.1007/s00198-023-06863-y.

MLA (9th ed.) Citation

Everts-Graber, Judith, et al. "Comparison of Anti-fracture Effectiveness of Zoledronate, Ibandronate and Alendronate Versus Denosumab in a Registry-based Cohort Study." Osteoporosis International, vol. 34, no. 11, 2023, p. 1961, https://doi.org/10.1007/s00198-023-06863-y.